TOP
Nav Bar
  1. General Info
  2. Effects Info
  3. Reference
Drug Details
01. General Information
Name Thymic stromal lymphopoietin
Drug Type Not Available
TTD ID DMOF95
Toxicity Organism Test Type Route(Dose)
Structure 2D-img
Download
2D MOL 3D MOL
02. Combinatorial Therapeutic Effect(s)
Synergistic Effect
Hide/Show
Decreasing Drug Toxicity
Hide/Show
Combination Pair ID: 859
Ref_1
Pair Name Acteoside, Thymic stromal lymphopoietin
Partner Name Acteoside
Disease Info [ICD-11: 2B33.4] Leukemia Investigative
Gene Regulation Down-regulation Expression BCL2 hsa596
Down-regulation Expression IL1B hsa3553
Down-regulation Expression IL6 hsa3569
Down-regulation Expression MDM2 hsa4193
Down-regulation Expression TNF hsa7124
In Vitro Model HMC-1 Mast cell leukemia Homo sapiens (Human) CVCL_0003
Result These results indicate that acteoside is a specific regulator of MDM2 activation in TSLP-stimulated mast cells, which indicates its potential use for the treatment of mast cell-mediated inflammatory diseases.
03. Reference
No. Title Href
1 Acteoside attenuates TSLP-induced mast cell proliferation via down-regulating MDM2. Int Immunopharmacol. 2015 May;26(1):23-9. doi: 10.1016/j.intimp.2015.03.003. Click
It has been 64978 visits since 2024.08
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang
TOP